John DiMatteo, MPH
John has more than 29 years of clinical operations and clinical program development experience with broad indication/therapeutic area experience and a major focus in neuroscience. He also supported mid and large biopharma drug development for more than 20 years, leading program teams for diabetic peripheral neuropathy (DPN) and other neuroscience indications and led operational program management of several neuroscience development programs.
John has supported New Drug Application (NDA) submission planning, most recently with purine nucleoside phosphorylase (PNP) deficiency and migraine. He has deep experience managing drug development teams and co-development partners in pharmaceutical product development in both the Rx and OTC landscapes.